The study analyzed nearly 500 tumors from domestic cats in five countries and found genetic alterations that closely resemble those in human cancers. Notable findings include p53 mutations in about one-third of samples and FBXW7 mutations in over half of cat mammary tumors. Researchers say the results strengthen the case for comparative oncology but caution that further research is needed to translate discoveries into treatments. Diet and shared environmental exposures are highlighted as areas for additional study.
Cat Cancer Genetics Mirror Human Tumors — Study Offers Clues for New Treatments
(Yale)
An international genomic analysis of feline tumors has revealed genetic changes that closely mirror those seen in human cancers, offering new avenues for comparative oncology, researchers and oncologists say.
The study, published in the journal Science, examined nearly 500 tumors collected from domestic cats across five countries. Investigators identified shared molecular alterations in cancers of the breast, blood, bone, lung, skin, gastrointestinal tract and central nervous system.
Key Genetic Parallels
Experts highlighted two notable genes. The tumor suppressor p53 was mutated in roughly one-third of the feline tumors — a frequency that matches many human cancer studies. Researchers also found frequent mutations in FBXW7, a gene linked to aggressive subtypes of breast cancer; more than half of the cat mammary tumors in the series carried FBXW7 alterations.
“This is certainly a way that we can look at cancer in a different way, looking at different gene mutations,” said Dr. Daniel Petrylak, professor of medicine and urology at Yale School of Medicine, commenting on the cross-species insights the work could provide.
Implications And Caveats
Researchers and clinicians say the genomic similarities make naturally occurring feline cancers a valuable model for studying how genetics and environment interact in tumor development. Dr. Geoffrey Wood, a pathobiology professor at the University of Guelph and co-senior author of the paper, described the field of feline cancer genomics as a former “black box” that this work helps illuminate.
However, experts caution that translation from genetic discovery to human therapies will require more research. Dr. Charles Simone, founder of the Simone Protective Cancer Institute, emphasized that additional studies are needed to determine whether these parallels can guide new treatments or help clinicians select existing drugs for individual patients.
Simone also noted a possible role for diet and shared household exposures: nutritional factors such as high-fat, low-fiber diets have been associated with cancer risk in humans, and many pet cats consume primarily commercial diets that may differ in fat content. He suggested this as an area for further investigation rather than a proven cause.
Next Steps
The authors say the findings establish a foundation for comparative studies that combine genomic data with environmental and clinical information in pets and people. Such work could accelerate discovery of cancer drivers and potentially identify treatment strategies that benefit both species.
Bottom line: The study reveals significant genetic overlap between cat and human cancers and underscores the promise of comparative oncology, while stressing that translational impact will depend on follow-up research.
Help us improve.
